Prior to synergy testing, the MLL‐rearranged ALL cell lines SEM, ALLPO, and KOPN8 were first pretreated with a low dose of 5 nM decitabine or corresponding vehicle (controls). Here, KMT2A is linked to acute lymphoblastic leukemia.